Fredholm B B, Zhang Y, van der Ploeg I
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug-Sep;354(3):262-7. doi: 10.1007/BF00171056.
Using the reverse transcription polymerase chain reaction (RT-PCR) we found that human neutrophils express mRNA for both A2A and A2B adenosine receptors, and using selective adenosine receptor agonists and antagonists we have characterized the type of adenosine receptor mediating inhibition of formyl-Met-Leu-Phe (fMLP)-induced oxidative burst. The order of potency of agonists was 5'-N-ethyl-carboxamidoadenosine (NECA) > 2-phenylaminoadenosine > 2-[p-(2-carbonyl-ethyl)-phenyl-ethylamino]-5'-N-ethyl-carboxamido adenosine (CGS 21680) > adenosine > N6-cyclopentyl-adenosine. This agrees with the agonist potency at human A2A receptors. The effect of adenosine was antagonized by 30 microM theophylline > caffeine = paraxanthine, i.e. concentrations close to those occurring in plasma after consumption of caffeine-containing beverages. The effect of NECA was unaltered by the A1 receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine, but inhibited by the A2A receptor selective antagonists 4-amino-8-chloro-1-phenyl-[1,2,4]-triazolo[4,3-a]quinoxaline (CP 66,713), 1,3-dipropyl-8-(3,4-dimethoxystyryl) -7-methylxanthine (KF 17387) and 8-(3-chlorostyryl)caffeine as well as by the non-selective, non-xanthine antagonist 5-amino-9-chloro-2-(2-furyl)-[1,2,4]-triazolo-[1,5-c]quinazoline methane sulphonate (CGS 15943). The adenosine receptor mediated responses were antagonized by the protein kinase A blocker Rp-cyclic adenosine 3',5'-phosphorothioate (Rp-cAMP). In conclusion, the adenosine-induced inhibition of neutrophil activation is mediated by adenosine A2A receptors.
利用逆转录聚合酶链反应(RT-PCR),我们发现人类中性粒细胞表达A2A和A2B腺苷受体的mRNA,并且使用选择性腺苷受体激动剂和拮抗剂,我们已经确定了介导甲酰甲硫氨酸-亮氨酸-苯丙氨酸(fMLP)诱导的氧化爆发抑制作用的腺苷受体类型。激动剂的效力顺序为5'-N-乙基-羧酰胺腺苷(NECA)> 2-苯氨基腺苷> 2-[对-(2-羰基-乙基)-苯基-乙氨基]-5'-N-乙基-羧酰胺腺苷(CGS 21680)>腺苷> N6-环戊基腺苷。这与人类A2A受体上激动剂的效力一致。腺苷的作用被30微摩尔的茶碱>咖啡因=对黄嘌呤拮抗,即这些浓度接近饮用含咖啡因饮料后血浆中出现的浓度。NECA的作用不受A1受体拮抗剂1,3-二丙基-8-环戊基黄嘌呤的影响,但被A2A受体选择性拮抗剂4-氨基-8-氯-1-苯基-[1,2,4]-三唑并[4,3-a]喹喔啉(CP 66,713)、1,3-二丙基-8-(3,4-二甲氧基苯乙烯基)-7-甲基黄嘌呤(KF 17387)和8-(3-氯苯乙烯基)咖啡因以及非选择性、非黄嘌呤拮抗剂5-氨基-9-氯-2-(2-呋喃基)-[1,2,4]-三唑并-[1,5-c]喹唑啉甲磺酸盐(CGS 15943)抑制。腺苷受体介导的反应被蛋白激酶A阻滞剂Rp-环腺苷3',5'-硫代磷酸酯(Rp-cAMP)拮抗。总之,腺苷诱导的中性粒细胞活化抑制是由腺苷A2A受体介导的。